Puma Biotechnology Inc

Historical 13F Holders

Symbol
PBYI
CUSIP
74587V107
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 74587V107 since 12/18/2024, largest first.

Filer % of Class Filed
Alan H. Auerbach 13D/A 16.0% 10/6/2026
Event 10/4/2026
Acorn Bioventures, L.P. 13G/A
8.0% 2/14/2025
Event 12/31/2024
BlackRock, Inc. 13G/A 5.6% 4/17/2025
Event 3/31/2025
American Century Investment Management, Inc. 13G
5.3% 11/16/2026
Event 9/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (4)
Millennium Management LLC 13G/A
3.9% 2/3/2025
Event 12/31/2024
Camber Capital Management LP 13G/A
0% 2/14/2025
Event 12/31/2024
Frazier Life Sciences Public Fund, L.P. 13G/A
0% 2/14/2025
Event 12/31/2024
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 160 40.4 M $402M
2026 Q2 161 38.7 M $314M
2026 Q1 158 37.9 M $242M
2025 Q4 153 35.3 M $210M
2025 Q3 136 34.4 M $183M
2025 Q2 122 32.8 M $113M
2025 Q1 118 30.4 M $90.0M
2024 Q4 113 29.4 M $89.7M
2024 Q3 102 29.7 M $75.8M
2024 Q2 100 31.0 M $101M
2024 Q1 97 29.7 M $158M
2023 Q4 83 26.6 M $115M
2023 Q3 71 25.7 M $67.6M
2023 Q2 70 26.6 M $93.8M
2023 Q1 79 27.9 M $86.1M
2022 Q4 90 27.5 M $116M
2022 Q3 84 27.7 M $65.5M
2022 Q2 90 27.9 M $79.5M
2022 Q1 106 29.9 M $86.1M
2021 Q4 103 30.3 M $92.2M
2021 Q3 118 32.2 M $226M
2021 Q2 122 34.8 M $319M
2021 Q1 119 36.6 M $356M
2020 Q4 125 35.3 M $362M
2020 Q3 129 36.1 M $364M
2020 Q2 131 35.1 M $366M
2020 Q1 128 36.6 M $309M
2019 Q4 136 31.3 M $274M
2019 Q3 146 36.6 M $394M
2019 Q2 141 35.0 M $445M
2019 Q1 162 34.2 M $1.32B
2018 Q4 143 35.2 M $717M
2018 Q3 158 35.9 M $1.64B
2018 Q2 176 36.2 M $2.13B
2018 Q1 179 35.6 M $2.42B
2017 Q4 205 36.2 M $3.61B
2017 Q3 174 36.7 M $4.39B
2017 Q2 160 35.5 M $3.10B
2017 Q1 139 38.0 M $1.41B
2016 Q4 130 34.9 M $1.07B
2016 Q3 153 30.0 M $2.01B
2016 Q2 111 31.8 M $948M
2016 Q1 121 30.4 M $893M
2015 Q4 136 32.2 M $2.52B
2015 Q3 165 30.2 M $2.27B
2015 Q2 201 30.5 M $3.55B
2015 Q1 202 29.1 M $6.87B
2014 Q4 190 27.1 M $5.14B
2014 Q3 187 26.7 M $6.37B
2014 Q2 141 25.4 M $1.68B
2014 Q1 138 25.1 M $2.62B